Siesta Medical’s AIRLIFT® Hyoid Suspension Demonstrates Broad Efficacy in Multicenter Study
Share Article
Siesta Medical, Inc., a leading provider of minimally invasive implants and tools for obstructive sleep apnea (OSA), announced the online publication of a recent study of the AIRLIFT procedure titled “Hyoid Suspension With UPPP for the Treatment of Obstructive Sleep Apnea” in the Ear, Nose & Throat Journal. This multicenter study evaluated the safety and efficacy of AIRLIFT hyoid suspension when combined with procedures for the palate on 39 patients treated at 3 centers. The median apnea hypopnea index (AHI) reduction was 74% while the AHI was reduced from 49.9 preoperatively to 15.4 after treatment. All patients saw a positive drop in their AHI assessment and 84% of patients with severe sleep apnea, the riskiest level of sleep apnea, improved to mild or moderate sleep apnea. In addition, the efficacy of the procedure appeared to independent of BMI, even in very high BMI